Cucumber mosaic cucumovirus (CMV) can be divided into two subgroups, I and II. LS-CMV and most other subgroup II strains cause a mild, systemic mottle on tobacco and can induce a necrotic etching (necrotic rings) symptom on inoculated tobacco leaves. In contrast, Fny-CMV and most other subgroup I strains cause severe, systemic mosaic symptoms on tobacco, but do not induce the necrotic etching symptom. Fulllength cDNA clones of all three genomic RNAs of LS-CMV were constructed and infectious RNAs were generated from these clones. Using pseudorecombinants constructed from the infectious transcripts of LS-CMV and Fny-CMV, we found that both RNAs 1 and 2 of Fny-CMV are involved in determining the severity of systemic symptom on tobacco, and that LS-CMV RNA 3 contains the determinant for the necrotic etching symptom. Chimeras formed between Fny-and LS-CMV RNA 3 were used to demonstrate that the inducer of the necrotic etching symptoms mapped to the 5' 618 nucleotides ofLS-CMV RNA 3, and required sequences in both the 5' non-translated region, as well as the 3a gene of CMV.
Introduction
Cucumber mosaic cucumovirus (CMV) has a positivesense, single-stranded genome consisting of three RNAs, namely RNA 1, RNA 2 and RNA 3. RNAs 1 and 2 encode one protein each, both of which are components of the viral replicase (Nitta et al., 1988; Hayes & Buck, 1990a) , while RNA 3 encodes two proteins: the 3a putative movement protein and the 25-5K viral coat protein (reviewed in Palukaitis et al., 1992) . CMV is one of the most widespread viruses known. CMV exists as a collection of strains with overlapping host ranges encompassing over 800 plant species (Douine et al., 1979; Kaper & Waterworth, 1981; Palukaitis et al., 1992) . The numerous strains of this virus, with a worldwide distribution, show differences in pathology and/or host range (Kaper & Waterworth, 1981) . CMV strains can be divided into two subgroups, I and II (Palukaitis et al., 1992) . The Fny strain of CMV (Fny-CMV), like most subgroup I strains, causes severe, systemic mosaic symptoms on tobacco. The full-length cDNA clones of all three RNAs of Fny-CMV were constructed previously in this laboratory (Rizzo & Palukaitis, 1990) . The LS strain of CMV (LS-CMV) is a t Present address: Kyushu National Agricultural Experiment Station, Kikuchi-gun, Kumamoto 861-11, Japan.
subgroup II strain of CMV and causes milder, systemic symptoms on tobacco (Wahyuni et al., 1992) as well as symptoms on the inoculated leaves consisting of numerous necrotic rings, or ' etching' (Fig. 1 a) . This latter symptom is specific to subgroup II strains, and is exhibited by over 20 subgroup II isolates in our collection (unpublished observation). By contrast, Fny-CMV ( Fig.  1 b) and over 30 subgroup I isolates in our collection do not cause the necrotic etching symptom (unpublished data). This symptom was also induced by the subgroup II strains W (Roberts & Wood, 1982) and R-CMV (Marchoux et al., 1975) . Using pseudorecombinants involving gel-purified viral RNAs between D-CMV (subgroup I) and R-CMV (subgroup II), Marchoux et al. (1975) demonstrated that the induction of necrotic etching mapped to R-CMV RNA 3. Here we describe the cloning of cDNAs representing the RNAs of LS-CMV, as well as the construction of pseudorecombinants and recombinants between LS-CMV and Fny-CMV and their use to delimit which viral sequences are involved in the above pathogenic responses in tobacco. (5' CCCTGCAGTGGTCTCCTT 3') was used to generate the first strand of cDNAs of LS-CMV RNAs 1 and 3. This primer contains a PstI site (underlined), followed by 10 nucleotides complementary to the 3' ends of all three LS-CMV RNAs. Since there are PstI sites in RNA 1 and RNA 2, another oligonucleotide (5' GGGAGCTCTGGTCTC CTT 3') was used to generate the first strand of cDNAs of LS-CMV RNAs 1 and 2. This primer contains a SacI site (underlined), followed by 10 nucleotides complementary to the 3' end of all three LS-CMV RNAs. The cDNAs were cloned into the plasmid vector pUC18 (Sambrook et al., 1989) and the termini of the inserts were sequenced using the Sequenase kit (United States Biochemical) to determine their orientation and the nature of the cDNA clones, i.e. LS-CMV RNA 1, 2 or 3. These cDNA clones were all 3' coterminal.
The cDNAs of the 5'-promixal sequences of the LS-CMV RNAs were generated according to the method of Ahlquist (1986) . The sequences of the specific primers were determined by partial sequencing of the clones and comparison with the RNA sequences of Q-CMV, which is a subgroup II CMV and is closely related to LS-CMV (Owen & Palukaitis, 1988; Palukaitis et al., 1992) . For LS-CMV RNA 1, an oligonucleotide (5'GATGATATCACGTCC 3') complementary to nucleotides 1612 to 1626 of LS-CMV RNA 1 was used to prime firststrand cDNA synthesis on total LS-CMV RNA. This primer contains an EcoRV site (underlined). After first-strand cDNA synthesis, secondstrand cDNA was primed using the oligonucleotide 5' GGGATCCTA ATACGACTCACTATAGGTTTTATTTAC 32 Six of the seven 5"-terminal nucleotides of this primer constitute a BamHI site (underlined), followed by 18 nucleotides that constitute most of the T7 RNA polymerase promoter sequence and 11 nucleotides that correspond to the viral 5' end sequence of Q-CMV RNA 1. For LS-CMV RNA 2, an oligonucleotide (5' GTTTTCTCTGCGCA 3') complementary to nucleotides 738 to 751 of Q-CMV RNA 2 (Palukaitis et al., 1992) was used to prime first-strand cDNA synthesis. This primer contains the single FspI site (underlined) in RNA 2. After first-strand cDNA synthesis, second-strand cDNA was primed using oligonucleotide
5' G G G A T C C T A A T A C G A C T C A C T A T A G G T T T A T T C T C 3'.
This primer also contains a BamHI site and a T7 RNA polymerase promoter sequence followed by 10 nucleotides that correspond to the viral 5' end sequence of Q-CMV RNA 2. For cDNA synthesis of the 5' 626 nucleotides of LS-CMV RNA 3, an oligonucleotide (5' CTACA CACGCTAGC 3') complementary to nucleotides 618 to 631 of Q-CMV RNA 3 was used to prime first-strand cDNA synthesis on total LS-CMV RNA. This primer contains an Nhel site (underlined). After first-strand cDNA synthesis, second-strand cDNA was primed using oligonucleotide 5' GGGATCCTAATACGACTCACTATAGGTAA TCTTAC 3'. This primer was also used in the construction of the fulllength cDNA clone of Fny-CMV RNA 3 (Rizzo & Palukaitis, 1990) .
The cDNAs representing the 5' termini of LS-CMV RNAs 1, 2 and 3 were amplified by the polymerase chain reaction (PCR) (Sambrook et al., 1989) and then cloned into the plasmid vector pUC18. The fulllength cDNA clones of LS-CMV were constructed by ligation of 5'-proximal PCR cDNA products of each RNA to the corresponding 3'-coterminal cDNA clones, using the restriction enzyme sites specified by the primers.
Construction and characterization of pseudorecombinants of Fny-and LS-CMV.
The Fny-CMV cDNA clones were linearized with PstI (Rizzo & Palukaitis, 1990) , while pLS-CMV 1, pLS-CMV 2 and pLS-CMV 3 were linearized with Sad, SphI and BamHI, respectively. The cDNA-derived infectious RNAs were generated by in vitro transcription with T7 RNA polymerase (Promega) following the procedure as described in the Promega Protocols and Application Guide. A 7-methylguanosine 'cap' structure (New England Biolabs) was incorporated at the 5' ends of the transcripts. Each transcript contains one extra G at the 5' end and various numbers of extra nucleotides at the Y end (one for PstI and Sad, seven for SphI and 14 for BamHI). The RNA transcripts from the full-length cDNA clones of LS-and Fny-CMV RNAs 1, 2 and 3 were combined to form the parental RNA, L1L~L 3 and F1F2F3, as well as six different pseudorecombinants, FIF2L3, FtLzF3, F1L2L~, LIFzF3, LIFzL a and LIL2F a. Each parental and pseudorecombinant RNA, without further purification, was diluted with 1 vol. 50 mM-sodium phosphate, pH 8-6, and inoculated (at 100 to 250 gg/ml) onto tobacco plants (Nicotiana tabacum cv. Xanthi nc). All the tobacco plants to be inoculated with transcripts were kept in the dark for 24 to 48 h and lightly dusted with carborundum before inoculation. Virus from the infected tobacco plants was purified (Palukaitis & Zaitlin, 1984) and the progenies of all pseudorecombinants were characterized by partial RNA sequencing (data not shown) and by a ribonuclease protection assay following the protocols and materials provided in the RT RNA sequencing kit (United States Biochemical) and the RPA II kit (Ambion), respectively.
Construction of RNA 3 chimeras between Fny-and LS-CMV.
The first pair of reciprocal chimeras was constructed using the common BamHI site upstream of the T7 promoter and the Nhel site which is in the 3a gene, 618 nucleotides from the 5' end of LS-CMV RNA 3 and 641 nucleotides from the 5' end of Fny-CMV RNA 3. The second pair of chimeras was constructed by exchanging Kpn! fragments, located at nucleotides 132 and 633 in Fny-CMV RNA 3 and nucleotides 108 and 609 in LS-CMV RNA 3. In vitro transcripts were generated from these reciprocal RNA 3 cDNA constructs, FLN 3 and LFN 3 (the NheI reciprocals), FLFK 3 and LFLK 3 (the KpnI reciprocals); each of which was mixed with the Fny-CMV RNAs 1 and 2 transcripts, and inoculated onto tobacco plants.
Partial RNA 3 sequence comparison and secondary structure analysis. The nucleotide sequence of the 5'-proximal 700 nucleotides [containing the 5' end nontranslated region (NTR) and the N-terminal two-thirds of the 3a gene] of LS-CMV RNA 3 was determined by partial dideoxynucleotide sequencing of LS-CMV RNA 3 as well as cDNA clones of LS-CMV RNA 3 following the protocols and materials provided in the RT RNA sequencing kit and Sequenase kit, respectively.
The nucleotide sequences of the 5'-proximal 350 nucleotides (containing the 5' end NTR and N-terminal part of 3a gene) of Fny-, LS-CMV RNA 3 and two RNA 3 chimeras (FLFK 3 and LFLK3) were folded into secondary structures by a computer program (GCG: Squiggles).
Results and Discussion

Construction o f full-length cDNA clones of LS-CMV and formation of six pseudorecombinants between Fnyand LS-CMV
Attempts to make full-length cDNA clones of the LS-CMV RNAs using the PCR and primers corresponding to the termini of each CMV RNA (Hayes & Buck, 1990b; Boccard & Baulcombe, 1992) 
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used to PCR amplify full-length cDNA of Fny-CMV RNA 2 using the cDNA clone pFny209 as a template (unpublished data) we assume the problem lies in the cDNA synthesis step from the RNA template. Thus, we used a three-step approach to make full-length cDNAs to each LS-CMV RNA. (i) A cDNA library was made using a primer specific to the 3' termini of each CMV RNA and a commercial cDNA synthesis kit. These cDNA clones contained sequences of either 50 % (RNA 1) or 80 to 95 % (RNAs 2 and 3) of the LS-CMV RNAs.
(ii) Primers complementary to internal sequences (deduced from the 3'-coterminal cDNA clones) and anticomplementary to the 5' terminus of each corresponding (subgroup II) Q-CMV RNA were used to prepare double-stranded cDNA to the Y-proximal regions. These cDNAs were amplified by the PCR prior to cloning. (iii) The corresponding cDNA clones of the Y-proximal and Y-coterminal sequences of each LS-CMV RNA were ligated together to construct fulMength cDNA clones. RNAs transcribed from each full-length cDNA clone were infectious when combined and inoculated to tobacco plants (Table 1 ). The RNA transcripts from the full-length cDNA clones of LS-and Fny-CMV RNAs 1, 2 and 3 were combined to form six different pseudorecombinants; F1FzLa, F1L2F3, FIL2L3, LIF2Fa, L1F2L 3 and LaLzF 3. The composition of these pseudorecombinants were confirmed by partial RNA sequencing (data not shown) and by a ribonuclease protection assay (Fig. 2) . Thus, all of the pseudorecombinants containing either RNA 1 of LS-CMV (Fig. 2 a) , RNA 2 of LS-CMV (Fig. 2b) or RNA 3 of LS-CMV (Fig. 2c) protected probes specific to those RNAs, whereas the other pseudorecombinants did not. These results were confirmed using the reciprocal Fny-CMV RNA specific probes (data not presented).
Systemic symptom determinants of Fny-CMV
The Fny-CMV infected tobacco plants usually show severe symptoms on the systemically infected leaves and no symptoms on the inoculated leaves. The symptoms of both Fny-CMV and F1F2F 3 appear as a light-green/ dark-green mosaic with leaf distortions (see Shintaku et al., 1992) . In contrast to Fny-CMV, LS-CMV causes mild mottle symptoms in systemically infected tobacco. To map which of the three RNAs of Fny-CMV determine(s) the severity of the systemic symptom on tobacco, we inoculated tobacco with the Fny-/LS-CMV pseudorecombinants, F~F2L3, FIL2Fa, F~L2L 3, L~F2F3, L1F2L 3 and L~L2F 3. The results showed that the F1F2L 3 infected tobacco plants produced severe systemic symptoms and L1LzF 3 infected plants exhibited mild systemic symptoms. While the severity of symptoms caused by F~L2F a and L1F2L3, FiL2L ~ and L1F2F 3 were very similar, they were not as severe as those caused by FIF2F a or FaF2L3, but were more severe than those caused by either LS-CMV, L1L2F 3 or L1L2L a (Table 1) . Therefore, we conclude that RNAs 1 and 2 of Fny-CMV are both involved in determining the severity of the systemic symptoms in tobacco. The yields of purified virus for the six pseudorecombinants, LS-CMV and the reconstituted parental virus, LIL~L3, were similar (Table 1) , and all were less than for the parental virus, F1F2F a. Thus, since FaF2L a and L1L2L 3 produced identical yields of virus, but F1F2L 3 produced systemic symptoms identical to F]F2F 3, the severity of the systemic symptoms does not correlate with the level of accumulation of the virus. The yield data also suggest there is no incompatibility between the encoded la and 2a proteins of the two subgroups that might affect RNA accumulations, and indirectly the pathology.
Local (necrotic etching) symptom determinants of LS-CMV
LS-CMV causes symptoms on the inoculated leaves of tobacco consisting of numerous necrotic rings, or ' etching' (Fig. 1 a) . Fny-CMV does not cause the necrotic etching symptom (Fig. 1 b) . Using the same pseudorecombinants (i.e. F1F~L 3, F1L2F3, F1L2L~, L1F2F3, LIF2L 3 and LIL~F3) the necrotic etching symptoms on the inoculated leaves were induced when the inoculum consisted of any combination that included LS-CMV RNA 3 (i.e. FiF2L ~, F]L2L 3 and LIF2L3; (Table 1) . Thus, RNA 3 of LS-CMV determines the production of the necrotic etching symptom on the inoculated leaves of tobacco.
To delimit which sequences within RNA 3 determine the induction of the necrotic etching symptom on the inoculated leaves of tobacco, chimeric recombinants were constructed between cDNA clones of RNA 3 of Fny-and LS-CMV. A pair of reciprocal chimeras was constructed using the common NheI site, 618 nucleotides from 5' end of LS-CMV RNA 3, and 641 nucleotides from the 5' end of Fny-CMV RNA 3. In vitro transcripts of these chimeras (FLN 3 and LFN3) were combined with transcripts of Fny-CMV RNAs 1 and 2 and then inoculated onto tobacco plants. The chimera containing LS-CMV RNA 3 sequences 5' of the NheI site (FIF2LFN3) induced necrotic ringspots (etching) on the inoculated leaf, whereas the reciprocal chimera (FIF2FLN3) did not (Fig. 3) . A second pair of chimeras was constructed by exchanging KpnI fragments to determine whether the 5'NTR or the 3a gene contained the sequences eliciting the necrotic etching symptoms. (Although the first KpnI site is within the amino terminus of the 3a gene, there are no nucleotide differences between the initiation codon and the first KpnI site.) In vitro transcripts were generated from these two reciprocal RNA 3 cDNA constructs, FLFK 3 and LFLK 3, separately mixed with the Fny-CMV RNAs 1 and 2 transcripts, and inoculated onto tobacco plants. No tobacco plants inoculated with either of the KpnI chimeras (FLFK 3 or LFLK3) showed the necrotic etching symptom (Fig. 3) , indicating that either sequences in both the 5'NTR and the amino-terminal twothirds of the LS-CMV 3a gene, or a secondary structure involving both regions and unique to the parental LS-CMV RNA 3, are important for the induction of the necrotic etching symptom in tobacco (Fig. 1 a) .
Partial RNA 3 sequence comparison and secondary structure analysis
To further delimit the mechanism of 'etching' induction by the 5'-proximal ca. 650 nucleotides of LS-CMV RNA 3, but not by the corresponding sequences of Fny-CMV RNA 3, the nucleotide sequence of the 5'-proximal 700 nucleotides (containing the 5'NTR and the aminoterminal two-thirds of the 3a gene) of LS-CMV RNA 3 was determined and aligned to the sequence of the same region of Fny-CMV RNA 3 (Fig. 4) . The 5'NTR of Fny-CMV RNA 3 contains additional nucleotides compared to the 5'NTR of LS-CMV RNA 3. In addition, there are 51 nucleotide differences (including deletions) between the 5'NTRs of the two RNAs 3, as well as 110 nucleotide differences within the 3a gene up to the Nhe! site. There are also 22 amino acid sequence differences in the encoded 3a protein up to the NheI site (Fig. 4) . The differences between Fny-and LS-CMV RNA 3 from the 5' end to the NheI site are too numerous to indicate which RNA or amino acid sequences could be the determinants for the induction of the necrotic etching symptom on the inoculated leaves of tobacco.
The 5'-proximal 350 nucleotide termini of RNA 3 of Fny-CMV and LS-CMV, and of the RNA 3 chimeras, FLFK3, and LFLK3, were folded into putative secondary structures (Fig. 5) . The predicted secondary structures of Fny-CMV RNA 3 (F3) and LS-CMV RNA 3 (L3) are very different from each other (Fig. 5 a, b) . The predicted secondary structure of FLFK 3 (Fig. 5 c) is similar to that of F 3, but not to L 3. This is consistent with FLFK 3 being unable to induce the necrotic etching symptom (Fig. 3) . The predicted secondary structure of LFLK 3 (Fig. 5 d) is more similar to that of L3, but they are still significantly different from each other in some regions. Another difference between L3 and LFLK 3 is that the aminoterminal two-thirds of the 3a protein of LFLK s is from F 3. Thus, if both the secondary structure of the RNA, and also the 3a protein are important factors in the induction of the necrotic etching symptom, then LFLK 3 also would not be able to induce necrotic etching. Hence, the necrotic etching symptom, which shows a distribution pattern suggestive of the path of virus movement (radial from the sites of infection and along veins; Fig. 1 a) , may be induced by interactions involving host factors with RNA sequences folded into specific structures and also with virus-encoded proteins, but not the latter alone. Experimental determination of the RNA secondary structure in the 5' 350 nucleotides of the various RNAs shown in Fig. 5 may help to delimit the various models for the nature of the inducer of the necrotic etching symptom.
